Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

729
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
729
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.0K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.0K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

16.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FedCAD: Cross-modal semantic alignment and distillation for cross-domain heterogeneous federated learning.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Optimising POU3F4 variant interpretation through gene-specific evidence in X-linked hearing loss.

EBioMedicine·2026
Same author

Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing.

EMBO molecular medicine·2026
Same author

A Cross-Species Single-Cell Atlas Reveals Conserved Regulatory Networks and Candidate Hearing Loss Genes in the Cochlea.

Genes·2026
Same author

In vivo epigenome editing reduces circulating lipids and attenuates atherosclerosis in mice.

Journal of genetics and genomics = Yi chuan xue bao·2026
Same author

The AudioGene Translational Dashboard for Diagnosing Autosomal Dominant Nonsyndromic Hearing Loss: Phenotypic Data Visualization and Analysis Study.

JMIR bioinformatics and biotechnology·2026

Related Experiment Video

Updated: Oct 3, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.8K

DVPred: a disease-specific prediction tool for variant pathogenicity classification for hearing loss.

Fengxiao Bu1,2, Mingjun Zhong3,4, Qinyi Chen4

  • 1Institute of Rare Diseases, West China Hospital of Sichuan University, Chengdu, 610000, China. bufengxiao@wchscu.cn.

Human Genetics
|February 19, 2022
PubMed
Summary

A new disease-specific tool, DVPred, accurately predicts the impact of genetic variants causing hearing loss (HL). This approach outperforms general tools by focusing on specific genes, improving variant classification for genetic disorders.

More Related Videos

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

589
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.1K

Related Experiment Videos

Last Updated: Oct 3, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.8K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

589
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.1K

Area of Science:

  • Genomics
  • Bioinformatics
  • Medical Genetics

Background:

  • Computational tools for variant impact prediction exist but struggle with accuracy and validity in diagnostics.
  • Existing pan-genome, pan-disease tools overlook crucial gene- and disease-specific properties.
  • Limited accessibility of curated data hinders the application of current prediction tools.

Purpose of the Study:

  • To develop a disease-specific prediction tool, Deafness Variant deleteriousness Prediction tool (DVPred), for genetic hearing loss (HL).
  • To leverage gene- and disease-specific properties for improved variant classification.
  • To demonstrate the utility of a disease-specific strategy for variant prediction tools.

Main Methods:

  • Developed DVPred using the gradient boosting decision tree (GBDT) algorithm.
  • Utilized a dataset of expert-curated pathogenic and benign variants from HL patients and public databases.
  • Incorporated both variant-level and gene-level features, including low complexity genomic regions and substitution intolerance scores.

Main Results:

  • DVPred achieved an area under the curve (AUC) of 0.98, outperforming universal tools.
  • Demonstrated consistent high performance (AUC = 0.985) on an independent assessment dataset.
  • Identified gene-level metrics as top predictive features, revealing gene-specific variant tolerance.

Conclusions:

  • DVPred's disease-specific strategy significantly improves deafness variant prediction accuracy.
  • The tool enhances prioritization of pathogenic variants from high-throughput sequencing data for HL genes.
  • Findings support the development of similar disease-specific prediction tools for other genetic disorders.